tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2025 Mar;31(3):636-638.
doi: 10.3201/eid3103.240594.
Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023-2024
Kaiming Bi, Shraddha Ramdas Bandekar, Anass Bouchnita, Spencer J Fox, Lauren Ancel Meyers
Projections for the US 2023-24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022-23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.
Keywords: COVID-19; SARS-CoV-2; United States; influenza; modeling; respiratory infections; respiratory syncytial virus; scenario projection; vaccine-preventable diseases; viruses; zoonoses.
. 2025 Mar;31(3):636-638.
doi: 10.3201/eid3103.240594.
Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023-2024
Kaiming Bi, Shraddha Ramdas Bandekar, Anass Bouchnita, Spencer J Fox, Lauren Ancel Meyers
- PMID: 40023827
- DOI: 10.3201/eid3103.240594
Projections for the US 2023-24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022-23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.
Keywords: COVID-19; SARS-CoV-2; United States; influenza; modeling; respiratory infections; respiratory syncytial virus; scenario projection; vaccine-preventable diseases; viruses; zoonoses.